Videndum PLC Reports Strong Q3 Order Growth and Progress on Debt Negotiations

Videndum’s Q3 momentum: strong order book and improving run-rate

Videndum’s latest update strikes a more upbeat tone. After a quiet July and August, orders picked up sharply in September, particularly in the US. As at 30 September 2025, the order book was up c.40% year-on-year, with September order intake 6% higher than the same month in 2024 – the best monthly intake in over a year.

Revenue is still down, but the trend is improving. Q3 revenue was 8% lower year-on-year, excluding the distortion from the 2024 Paris Olympics, compared with a 25% decline in the first half. That signals a clear sequential recovery in the run-rate.

Quick jargon check: “order book” is the value of confirmed orders not yet delivered. When the order book grows, it tends to convert into revenue over the next few months.

Profitability: EBITDA rebound and cost savings kicking in

The company’s cost actions are starting to bite. Videndum reiterated that previously announced £19 million cost saving programmes are coming through as expected. Q3 EBITDA was 50% higher than in H1, helped by improving activity and the leaner cost base.

EBITDA stands for earnings before interest, tax, depreciation and amortisation – a cash proxy that lenders and investors often use to gauge operating performance. Management highlights that market inventory is limited, so any uptick in demand should flow through quickly to revenue, and given the cost resets, more of that revenue should drop through to operating profit.

Importantly, the Board’s expectations for FY26 remain unchanged. That suggests management sees the current traction as consistent with the medium-term plan.

Debt and covenants: what the RCF lenders are asking for

Videndum says it continues to make constructive progress with its banks on a deleveraging plan and it met its September EBITDA covenant. That is a critical marker of stability after a tough period.

The lenders have now requested two things in October: agree the deleveraging plan and meet a new trailing last twelve-month October EBITDA covenant of £10 million. The company calls this a stretching target, but it has agreed to it. Videndum also says it expects that if trading falls short or the deleveraging plan is not agreed, lenders will waive or defer both covenants. That expectation is helpful, but it is still contingent on lender support.

Quick jargon check: RCF means revolving credit facility – a flexible bank line. A covenant is a financial condition set by lenders. Breaching a covenant can trigger waivers, fees, or in the worst case a default, so staying in compliance or securing waivers matters.

Deleveraging plan: new liquidity likely from disposals, debt or equity

Management reiterates a key point from the April and August RNS updates: any deleveraging plan will require alternative new sources of liquidity. That could include proceeds from disposals and the raising of new debt or equity, or a combination.

Translation for investors: asset sales reduce leverage but can also shrink earnings power if core assets are sold. New debt preserves equity but raises interest costs and refinancing risk. New equity strengthens the balance sheet but dilutes existing shareholders. The mix will matter for valuation.

The timeline is tight. Banks want the plan agreed in October. Expect further announcements at short notice as negotiations progress.

JOBY sale: modest cash in, balance in escrow

Videndum has completed the sale of its consumer-oriented JOBY brand to VIJIM. Gross cash proceeds are c.£5 million, with 80% already received and the remaining 20% held in escrow to follow within six months.

Quick jargon check: escrow means funds are held by a third party and released once agreed conditions are met. The cash is helpful, though small compared to the group’s debt position, and underscores that further actions will be needed to deleverage.

Net debt snapshot: leverage remains the key risk

Net debt as at 30 September 2025 was £139 million, including £27 million of finance leases. That is the headline number to watch while the deleveraging plan is hammered out. No leverage ratio is disclosed in this update, so we cannot judge debt against EBITDA here, but the covenant focus from lenders tells you the balance sheet remains the central issue.

On the positive side, improving order intake and low market inventory should help cash conversion if orders ship on time. However, the October covenant and plan deadlines introduce event risk in the near term.

Why this update matters: the bull case vs the bear case

The bull case – operational momentum is back

• Order book up c.40% year-on-year at 30 September 2025, with September the best intake in over a year.
• Q3 revenue down 8% year-on-year (ex-Olympics), a big improvement from the 25% first-half decline.
• Q3 EBITDA 50% higher than H1, supported by £19 million in cost savings.
• Board expectations for FY26 unchanged, signalling confidence in medium-term recovery.

The bear case – balance sheet and October covenant risk

• Net debt of £139 million, including £27 million of finance leases, keeps leverage in focus.
• Lenders have set a stretching last twelve-month October EBITDA covenant of £10 million and want the deleveraging plan agreed this month.
• Deleveraging will likely require asset sales and/or new debt or equity – each option has trade-offs, including potential dilution for shareholders if equity is raised.
• JOBY sale proceeds of c.£5 million are helpful but small versus the overall debt position.

Key numbers at a glance

Order book (30 Sept 2025)	Up c.40% year-on-year
September order intake	+6% year-on-year (highest in over a year)
Q3 revenue	Down 8% year-on-year (excluding 2024 Paris Olympics impact)
H1 revenue	Down 25% year-on-year
Q3 EBITDA vs H1	Up 50%
Cost saving programmes	£19 million
Net debt (30 Sept 2025)	£139 million (including £27 million of finance leases)
JOBY sale proceeds	c.£5 million (80% received; balance in escrow within six months)
Lender request	Trailing LTM October EBITDA covenant of £10 million and October agreement of deleveraging plan

What to watch next: October deadlines and FY26 setup

• Deleveraging plan: terms, timing and mix of disposals, new debt or equity. Any equity raise would be dilutionary, scale not disclosed.
• Covenants: whether the new October EBITDA covenant is met or waived or deferred by lenders as the company expects.
• Trading updates: confirmation that the stronger order book is converting to revenue and cash as inventories remain tight.
• Further disposals: whether additional non-core asset sales are executed and at what valuations.

My take

This is a more encouraging trading update from Videndum. Orders are finally moving, revenue declines are narrowing, and cost savings are driving a meaningful EBITDA rebound. The Board holding FY26 expectations unchanged suggests confidence that the recovery is becoming established.

The challenge is the balance sheet. Net debt of £139 million and a fresh covenant hurdle of £10 million LTM EBITDA in October keep the pressure on. The expectation of lender flexibility is helpful, but investors are still facing an eventful October as the deleveraging plan is agreed. If momentum continues and lender support holds, the operational turnaround can show through more cleanly. If not, the mix of disposals and potential equity could reshape the equity story. For now, execution and covenant management are everything.